A groundbreaking initiative from the National Kidney Foundation to improve chronic kidney disease (CKD) testing, recognition, and management in primary care.
Overview
Only 10% of people living with CKD are aware that they have CKD. CKDintercept is a broad national strategy to improve CKD testing, diagnosis, and management in primary care. Our goal is to ensure that everyone living with CKD receives a timely diagnosis, high quality care, and the information necessary to make informed healthcare choices.
Program Components
Utilizing the Collective Impact model , these activities convene diverse healthcare and public health stakeholders to develop local strategies to improve CKD population health in their communities.
Community Health Workers (CHW) play an important role in the prevention of CKD by educating and helping the communities they serve. The NKF is developing training materials for CHWs to understand CKD.
Use existing data to assess and address chronic kidney disease (CKD) in at-risk populations.
U.S. Clinical Laboratories Lead the Way in Advancing Early Diagnosis of Chronic Kidney Disease
Under the NKF's CKDintercept initiative, pharmacists play a crucial role in the early detection, testing, and management of chronic kidney disease (CKD). They are vital members of the healthcare team, contributing to the improved identification of early CKD and the effective management of the disease, along with its associated cardiovascular risks.
CKD Toolkits
Tools designed to catalog educational information and resources related to kidney disease for health professionals and the general public.